These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25259564)

  • 21. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of MMP9 and TIMP2 in Patients with Varicose Veins.
    Kunt AT; Isbir S; Gormus U; Kahraman OT; Arsan S; Yilmaz SG; Isbir T
    In Vivo; 2015; 29(4):461-5. PubMed ID: 26130791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
    Banday MZ; Sameer AS
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
    [No Abstract]   [Full Text] [Related]  

  • 24. Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
    Oszajca K; Szemraj M; Szemraj J; Jurowski P
    Ophthalmic Genet; 2018 Dec; 39(6):684-698. PubMed ID: 30289322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-2 -735C/T polymorphism is associated with resistant hypertension in a specialized outpatient clinic in Brazil.
    Sabbatini AR; Barbaro NR; de Faria AP; Ritter AMV; Modolo R; Correa NB; Brunelli V; Pinho C; Fontana V; Moreno H
    Gene; 2017 Jul; 620():23-29. PubMed ID: 28390988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2 is genetic predisposing factors for prevalence of moyamoya disease.
    Park YS; Jeon YJ; Kim HS; Han IB; Oh SH; Kim DS; Kim NK
    BMC Neurol; 2014 Oct; 14():180. PubMed ID: 25280484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
    Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
    Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion.
    Ortak H; Demir S; Ateş O; Söğüt E; Alim S; Benli I
    Exp Eye Res; 2013 Aug; 113():151-5. PubMed ID: 23791966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.
    Wieczorek E; Reszka E; Jablonowski Z; Jablonska E; Krol MB; Grzegorczyk A; Gromadzinska J; Sosnowski M; Wasowicz W
    BJU Int; 2013 Dec; 112(8):1207-14. PubMed ID: 23819551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis.
    Piotrowski WJ; Górski P; Pietras T; Fendler W; Szemraj J
    Med Sci Monit; 2011 Oct; 17(10):CR598-607. PubMed ID: 21959615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease.
    Park KS; Min Y; Park SR; Kim EH; Lee DJ; Bang D; Lee ES
    Tissue Antigens; 2012 May; 79(5):333-9. PubMed ID: 22428754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A
    Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.
    Alakus H; Afriani N; Warnecke-Eberz U; Bollschweiler E; Fetzner U; Drebber U; Metzger R; Hölscher AH; Mönig SP
    World J Surg; 2010 Dec; 34(12):2853-9. PubMed ID: 20730428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
    Srivastava P; Kapoor R; Mittal RD
    Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
    Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
    Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer.
    Yaykaşli KO; Kayikçi MA; Yamak N; Soğuktaş H; Düzenli S; Arslan AO; Metın A; Kaya E; Hatıpoğlu ÖF
    Turk J Med Sci; 2014; 44(5):839-43. PubMed ID: 25539555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for matrix remodelling proteins in invasive and malignant meningiomas.
    Jalali S; Singh S; Agnihotri S; Wataya T; Salehi F; Alkins R; Burrell K; Navab R; Croul S; Aldape K; Zadeh G
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e16-28. PubMed ID: 24989599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.